Testagen
Testagen (Lys-Glu-Asp-Gly) is a synthetic Khavinson bioregulator peptide marketed for testicular/reproductive support. Evidence is limited to preclinical work and Russian reports; no independent human trials exist, and it is not a testosterone-boosting drug in any validated sense.
01 Overview
Testagen is a tetrapeptide bioregulator claimed to target the testes and support reproductive function and spermatogenesis. Developer-group animal studies report effects on testicular tissue and gene expression.\n\nDespite marketing that implies hormonal enhancement, there is no independent human trial evidence that Testagen raises testosterone or improves fertility. It is sold as a research peptide.
02 Mechanism
Proposed tissue-specific regulation of testicular cell gene expression; no validated effect on the HPG axis or serum testosterone.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Anecdotal | 5–10 mg/day | IM | Short cycled courses per vendor protocols; no clinical basis. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Testicular tissue supportReported effects on testicular tissue in animal models. | n/a | Preclinical | |
| Fertility/reproductive claimMarketed for spermatogenesis support; unverified in humans. | n/a | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Unfounded hormonal expectationsUsers may expect testosterone increases that the peptide has not been shown to produce, delaying real evaluation of hypogonadism. | Mild | Situational | Unconfirmed | |
| Injection-site reactionLocal irritation at injection sites. | Mild | Common | Anecdotal |